Merck’s struggles with HPV vaccine send stock to worst selloff in almost 17 years
Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset ...
Should You Pick MRK Stock At $90?
Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates.
Kennedy to divest interest from HPV vaccine lawsuits
President Donald Trump’s Health and Human Services nominee said he will divest his interest in lawsuits against an HPV ...
Merck's 2025 revenue outlook falls short as it pauses Gardasil vaccine shipments to China
Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...
CBS News7d
What to know about RFK Jr.'s financial ties with a personal injury law firm
continues to support the safety and efficacy profiles of our HPV vaccines," Rahway, New Jersey-based Merck said Tuesday in a statement on the litigation. "The plaintiff's allegations have no merit ...
ABC News10d
RFK Jr. says he’s not anti-vaccine. But he could profit off claim in vaccine lawsuit.
He says, if confirmed, he can still earn referral fees from a firm suing Merck ... or HPV -- and later grew sick. Public health researchers and doctors said there was no evidence that the vaccine ...
ABC News7d
In major reversal, Kennedy tells senators he won't take money from vaccine lawsuit
The lawsuit alleges marketing fraud against pharmaceutical company Merck for its HPV vaccine, Gardasil, which Merck denies. The Centers for Disease Control and Prevention (CDC) maintains that the ...